Carlson Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,081,091
Closed -$306M 324
2019
Q3
$306M Buy
3,081,091
+191,566
+7% +$18.2M 5.53% 1
2019
Q2
$267M Buy
2,889,525
+542,022
+23% +$51.5M 4.04% 2
2019
Q1
$221M Buy
+2,347,503
New +$205M 3.93% 3
2017
Q2
Sell
-106,350
Closed -$13.2M 325
2017
Q1
$13.2M Buy
+106,350
New +$12.7M 0.17% 169

Other funds holding CELG

Carlson Capital's CELG Position: Q4 2019 in Review

Carlson Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,081,091 shares — an estimated $306M sold.

Carlson Capital first reported a position in CELG in Q1 2017 and held it in 4 quarters. The position peaked at $306M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Carlson Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Carlson Capital sold 3,081,091 Celgene Corp shares in Q4 2019, an estimated $306M.
  • Carlson Capital first reported a position in Celgene Corp in Q1 2017 and held it in 4 quarters.
  • Carlson Capital's Celgene Corp position peaked at $306M in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Carlson Capital's 13F filing for Q4 2019, filed 14 Feb 2020.